Literature DB >> 27312266

Corrigendum to "Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A" [Contraception 2016;93:498-506].

Patrick Rowe1, Tim Farley1, Alexandre Peregoudov1, Gilda Piaggio2, Simone Boccard1, Sihem Landoulsi3, Olav Meirik4.   

Abstract

Entities:  

Year:  2016        PMID: 27312266      PMCID: PMC5357721          DOI: 10.1016/j.contraception.2016.06.001

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


× No keyword cloud information.
We wish to make the following corrections to our article in the June 2016 issue of Contraception [1]. Page 498, first sentence of the Abstract should read: To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) intrauterine device (LNG-IUD) or the copper T 380 A IUD (TCu380A). Page 500, left column, first paragraph, first sentence should read: The trial was initially planned for at least 10 years of follow-up of use of the IUDs. Page 504, right column, third paragraph, third sentence should read: The rate of discontinuation due to increased bleeding is slightly higher for the LNG-IUD than for the TCu380A in Chinese centres, while in non-Chinese centres, this pattern is reversed.
  1 in total

1.  Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.

Authors:  Patrick Rowe; Tim Farley; Alexandre Peregoudov; Gilda Piaggio; Simone Boccard; Sihem Landoulsi; Olav Meirik
Journal:  Contraception       Date:  2016-02-23       Impact factor: 3.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.